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Abstract
During B cell development, V-J rearrangements at the Ig heavy \i chain (IgH \i chain) locus occur
In early cycling precursors (pro-B stage). Subsequently, rearrangements at the Ig light (IgL) chain
locus occur In late resting precursors (small pre-B stage). To study the effects of \i chain
expression on the rate of B cell development, purified hematopoletlc stem cells (HSC) bearing a ji
chain transgene or wild-type HSC were transferred Into Immunodeflclent RAG-2^~ mice and B cell
development was followed over time. In addition, cycling B cell precursors were pulse-labeled by
the Injection of BrdU into transgenlc and wild-type mice, and the production of BrdU-labeled K +
and X+ B cells was followed over time. These experiments suggested that early expression of the u
chain from the transgene significantly shortened the duration of the pro-B stage and Immediately
drove the precursors to differentiate into small pre-B cells. By contrast, the presence of the
transgene did not affect the small pre-B stage, where IgL rearrangements occur. Thus, K and X
rearrangements occurred only after the arrest of cell cycling as previously shown In wild-type
mice, even when the u chain is artificially expressed earlier In B cell development
Introduction
Based on the state of cell cycling and the expression of the
Vpre.B/^5 surrogate light (SL) chain and IgH n chain, CD45R+
(B220+) B cell precursors can be subdivided into four stages:
pro-B [cycling, SL+cytoplasmic-tr(c-n~)], large pre-B (SL+c-
\i+ or SL"c-n+), small pre-B (resting, SL~c-n+) and newly-
generated immature B cells [resting, surface-lgM+ (slgM+)]
(1-4). Rearrangements at the IgL loci (the Igic and IgA. loci)
occur mostly in the small pre-B cell stage (5-7). Thus, B cell
precursors can be more simply subdivided into two stages:
early cycling precursors and late resting precursors, which
undergo rearrangements at the IgL locus.
A defect in the expression of the |i chain arrests B cell
development at the pro-B stage (8,9), as seen in RAG-2^'
mice, which are unable to undergo V(D)J recombination
(10,11). This block can be released in RAG-2^rr\\ce bearing
a n chain transgene, and pro-B cells can differentiate into
large pre-B cells and then into small pre-B cells (12-14). The
presence of the n chain is thus essential for the differentiation
of early cycling precursors into late resting precursors.
While it is clear that \L chain expression suppresses another
VH to DHJH rearrangement (15-17), it has been debated
whether the expression of the \i chain activates VK-JK
rearrangements (18). Transfection of a n chain gene into an
Abelson murine leukemia virus (A-MuLV)-fransformed pre-B
cell line, p17-27, induced vV-JK rearrangements, supporting
a role for the i^ chain in the activation of VK-JK rearrangements
(19-21). JH-deficient mice, however, can initiate low levels of
VK-JK rearrangements (22). Hence, V ^ ^ rearrangements can
be initiated without the \L chain, whereas it remains unclear
whether or not the expression of the \i chain gives rise to
signals for enhancing IgL rearrangements.
While previous studies have shown that the i^ chain is
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essential for the generation of small pre-B cells, the present
study addresses the effect of the (i chain on the rate of B
cell differentiation. For this purpose, we analyzed B cell
development with time in vivo comparing n chain transgenic
and non-transgenic mice. The transgene expressed the n
chain very early during B cell development causing the
inhibition of endogenous VH to DHJH rearrangements (data
not shown). The results indicated that early expression of the
H chain from the transgene significantly accelerated B cell
development in the early cycling precursor stage but did not
affect the late resting precursor stage.
Methods
Mice
Breeding stocks of RAG-Z^~ mice (Ly5.1~Ly5.2+) were kindly
provided by Drs C. Reeder (NCI, Frederick, MD) and F. Alt
(The Children's Hospital, Boston, MA). Mice carrying the Sp6
H chain transgene (23) were provided by Dr Antonio Iglesias
(Max-Planck-lnstitute for Immunology, Freiburg, Germany)
and back-crossed twice with C57BL/6 mice to obtain mice
heterozygous for the transgene and non-transgenic litter-
mates. The presence of the transgene was verified by staining
the peripheral blood with an anti-idiotype antibody (24). Mice
were maintained at the animal facility at the Basel Institute
under specific pathogen-free conditions.
Antibodies for flow cytometry
The following primary antibodies were used in this study:
phycoerythrin (PE)-coupled ACK-4 [anti-c-M (25); PharM-
ingen, San Francisco, CA], FITC-, PE- or allophycocyanin-
coupled RA3-6B2 [anti-B220/CD45R (26); PharMingen], FITC-
or biotin-conjugated 104-2.1 [anti-Ly5.1 (27)], FITC-or biotin-
conjugated A20-1.7 [anti-Ly5.2 (27)], biotin-conjugated goat
anti-K antibody (Southern Biotechnology, Birmingham, AL),
biotin-conjugated LO-MM (anti-mouse IgM; Caltag, San Fran-
cisco, CA), biotin-conjugated R26-46 [anti-mouse X, and X2
light chain (28), PharMingen], PE-conjugated 217-170 [anti-
mouse lgDb (29); PharMingen]. Second step reagents
included streptavidin-TriColor (Caltag) or streptavidin-
Red613 (Gibco/BRL, Gaithersburg, MD).
Injection of hematopoetic stem cells (HSC) into RAG-2^' mice
Bone marrow cells were taken from 5- to 7-week-old transgenic
and non-transgenic littermates. The CD45R~c-/o/"9h popula-
tion was purified by sorting and 10" purified cells from n
chain transgenic or non-transgenic littermates were injected
i.v. into 4 Gy irradiated RAG-2~*~ mice.
Immunofluorescence staining, analysis and cell sorting
For phenotypic analysis, single cell suspensions from bone
marrow were stained with mAb as indicated in the figure
legends. Cells (1-3X106) were incubated with purified mAb
at 5-10 ng/ml in PBS/5% FCS for 15-30 min on ice and washed
once with PBS/5% FCS. Flow cytofluorometric analysis was
performed on a FACscan (Becton Dickinson, Mountain view,
CA). Three-color staining of anti-Ly5.1/anti-Ly5.2/anti-CD45R,
anti-Ly5.2/anti-CD45R/anti-K and Ly5.2/anti-CD45R/anti-X was
used to quantitate donor-type CD45R+, S-K+ and s-X+ B cells
respectively. Cells present in the lymphocyte gate, as defined
by light scatter (30), were analyzed to examine tc+ and X+
B cells. Fluorescence data are presented as logarithmic
histograms or dot plots, using Lysys software (Becton Dickin-
son). Sorted cell populations were reanalyzed for their purity
and were found to be >98% pure.
PCR analysis to quantitate recombination
From the bone marrow of recipient mice, Ly5.1+Ly5.2~B220+
donor-type B-hneage cells were sorted and stored as 5 \i\
aliquots containing 1000 cells in 0.5 ml microtubes at -70°C.
The protocol of Ehlich etal. (22) was followed for PCR analysis
of DNA rearrangements. Amplified samples were run on a
1.5% agarose gel, followed by Southern blotting. The filter was
hybridized, following a previously described protocol (22,31).
BrdU labeling in vivo and detection of Brdil+ B cells in the
bone marrow by flow cytometry
5-Bromo-2-deoxyuridine (Sigma, St Louis, MO) was dissolved
in PBS at 1 mg/ml. Mice were injected i.p. with 200 (ig BrdU.
Mice were killed at various time points and the bone marrow
cells were isolated. Sorter purified cells (CD45RlowslgM~,
B220bwslgM+slgD-K+, CD45Rk)wslgM+slgD-X+) were treated
as described previously (32). Cells were stained with FITC-
labeled anti-BrdU antibody (Becton Dickinson) and underwent
cytofluorometric analysis. Unlabeled cells stained with anti-
BrdU mAb and labeled cells lacking anti-BrdU mAb staining
were used as negative controls.
Results
Transferred bone marrow stem cells reconstituted B cell
compartments in RAG-2^' recipient mice
HSC purified from |i chain transgenic and non-transgenic
littermates were transferred into RAG-2~h mice. After the
engraftment (time zero), B cell development from injected
HSC was followed over time. The CD45R(B220)-c-Mh|9h
fraction (1.4% among nucleated cells in the bone marrow
of n chain transgenic and non-transgenic littermates; Fig.
1A, R2) was sorted to purify HSC. The c-ki^h fraction has
been reported to contain HSC, while the c-kit°" fraction
contains committed hematopoietic precursors (25,33,34). In
addition, (i chain expression has been shown to down-
regulate the expression of c-kit (35). As such, the CD45R"
c-Mh '9h fraction did not contain committed B cell precursors.
A total of 104 sorted cells from (i chain transgenic or
non-transgenic littermates were injected i.v. into Y-irradiated
(4 Gy) Ly5.1"Ly5.2+ RAG-2+ mice. Figure 1(B) shows the
flow cytometric analysis of B cell development in the bone
marrow at 23.5 days after the injection of HSC derived
from non-transgenic mice. Ly5.1+Ly5.2~ donor-type cells
can be distinguished from Ly5.1~Ly5.2+ host-type cells by
the absence of the Ly5.2 congenic marker (the R3 gate
shown in Fig. 1B, d). The (e) and (f) dot plots in Fig. 1(B)
display cells present in both the gate for lymphocytes (R1)
and the gate for donor-type cells (R3). The percentage of
surface tc+ B cells among the donor-type CD45R+ cells
was calculated to be 21.1% based on the following
calculation: 7 . 4 % ( K + C D 4 5 R + cells)/35%(total CD45R+
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Rg. 1. Purification of HSC and analysis of bone marrow of a recipient mouse engrafted with the purified HSC. (A) Purification of HSC. Bone
marrow cells were stained by two-color flow cytometry to measure the expression of CD45R (8220) and c-kil The R1 gate was defined in a
dot plot of forward scatter (FSC) versus side scatter (SSC) (a). Cells presented in the R1 gate are displayed in the (b) dot plot and the R2
gate was defined as c-Mhio"CD45R-. The cells in both the R1 and R2 gates represented the HSC fraction, and the sorted cells were injected
into 4-Gy-irradiated Ly5 2 + RAG-2+~ mice. (B) Analysis of cells in a reconstituted mouse Bone marrow cells were analyzed by three-color
flow cytofluorometry to measure the expression of Ly5.2 versus CD45R versus K, and Ly5 2 versus CD45R versus X, in an unreconstituted
RAG-Z^ (RAG-2T) mouse (d) and a reconstituted RAG-2+ mouse (d-f) Cells present in the gate, which is indicated on each dot plot, are
displayed (c-f) Donor-type cells (Ly5.1+Ly5 2") in the reconstituted mouse were identified by the absence of the recipient marker, Ly5.2 (R3
gate in d) and cells in both the R1 and R3 gates are displayed in the (e) and (f) dot plots in (B). The percentage of CD45R+ B-lineage cells
among donor-type cells is shown by numbers on the left in (e) and (f), and numbers on the right in these indicate the percentage of C D 4 5 R + K +
(e) and CD45R+X+ cells (f) among the donor-type cells
cells)xioo%. Similarly, the percentage of surface X+ B
cells among the donor-type CD45R+ cells was calculated to
be 4.3% based on the following calculation: 1.5%(X+CD45R+
cells)/35%(total CD45R+ cells)xi00%.
The early expression of transgenic // chain advanced the
generation of slgM+ B cells
Figure 2(A) represents the flow cytometric analysis of bone
marrow cells from n chain transgenic and non-transgenic
littermates. Figure 2(B) shows an identical analysis to that
discussed in Fig. 1(B), i.e. flow cytometric analyses of bone
marrow cells from reconstituted mice sacrificed at the indi-
cated days postgrafting. The percentage of smaJI pre-B cells
was slightly smaller in a n chain transgenic mouse than in a
non-transgenic littermate (64 versus 70%, Fig. 2A). By con-
trast, the histograms in Rg. 2(B) show that transferred trans-
genic HSC (HSC derived from n chain transgenic mice)
consistently yielded higher percentages of small pre-B cells
than transferred non-transgenic HSC. The dot plots in Fig.
2(B) show that transgenic HSC produced K+ B cells by
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Fig. 2. HSC bearing transgenic \i chain gave rise to small pre-B cells and K + B cells earlier than non-transgemc HSC in the reconstituted
mice. (A) Flow cytometric analysis of B cell precursors in the bone marrow of n chain transgenic and non-transgenic littermates. Histograms
show the forward scatter (FSC) of CD45RlowslgM~ B cell precursors as defined by the A gate in the dot plots. The numbers in the histograms
show the percentage of small pre-B cells among the CD45RlowslgM~ B cell precursors. Dot plots display the whole population of mononuclear
cells. The numbers in the dot plots show the percentage of newly-generated CD45R I O WK+ B cells (B gate) among the whole CD45Rk)w cell
population (A + B gates). CD45Rwoh cells were not counted, because they were recirculated from the periphery (30). (B) Reconstituted RAG-
2~*~ mice were sacrificed on the indicated days postgrafting and the bone marrow cells were analyzed as shown in Fig. 1(B). The histograms
show the forward scatter (FSC) of the Ly5 2XD45R+slgM" fraction (donor-type B cell precursors) in the first and third rows of Fig. 1(B) The
numbers represent the percentage of small pre-B cells among the donor-type B cell precursors. The dot plots show the expression of K versus
CD45R (B220) of Ly5.2~ donor-type cells. Numbers given in the dot plots indicate the percentage of K+ B cells among the donor-type
CD45R"1" cells.
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Fig. 3. B cell development from transferred HSC in recipient mice. (A-D) Each circle represents the result for an individual reconstituted
mouse The reconstitution of donor-type cells is compared between recipient mice engrafted with HSC from the \i chain transgenic mice
(closed circles) and those engrafted with HSC from non-transgenic littermates (open circles) The percentage of donor-type cells among all
nucleated bone marrow cells (A), the percentage of CD45R+ cells among the donor-type cells (B), and the percentage of K+ B cells (C) and
X+ B cells (D) among the donor-type CD45R+ cells are displayed. Time zero represents the day of engraftment.
9.5 days postgrafting, while non-transgenic HSC produced
essentially no K+ B cells until 12.5 days postgrafting.
Figure 3 summarizes the time course of B cell development
from transferred HSC in recipient mice and each dot
represents an individual recipient mouse. The percentages
of donor-type cells among nucleated bone marrow cells (Fig.
3A), CD45R"1" (B220+) cells among donor-type cells (Fig. 3B),
and K+ B cells (Fig. 3C) and A.+ B cells (Fig. 3D) among
donor-type CD45R+ cells were compared between host mice
transferred with non-transgenic HSC (open circles) and those
grafted with transgenic HSC (closed circles). The two groups
of recipients produced donor-type CD45R+ cells at the same
time, 8-10 days postgrafting (Fig. 3B). Although transgenic
and non-transgenic HSC differentiated into CD45R+ cells at
the same time postgrafting, transgenic HSC differentiated into
slgfvT B cells earlier than non-transgenic HSC. In fact,
transgenic HSC yielded substantial numbers of K+ B cells as
early as day 8 and the percentage of K+ B cells among
donor-type CD45R+ cells increased around day 11 (Fig. 3C).
In marked contrast, in the mice reconstituted with non-
transgenic HSC, K+ B cells were virtually undetectable until
12.5 days postgrafting and the number of K+ B cells rose
rapidly at 13 days postgrafting.
Consistent with the generation of K+ B cells, transgenic
HSC yielded substantial numbers of X+ B cells 9-13 days
postgrafting, while non-transgenic HSC were not capable of
generating X+ B cells during this period (Fig. 3D).
The early expression of the n chain from the transgene
advanced the onset of K rearrangements
In order to assess VK-JK rearrangements among donor-type
precursors, the relative numbers of VK-JK joints in donor-type
CD45R+ cells were measured by FCR (36) at various times
postgrafting. The assay for VK-JK joints was restricted to
rearrangements involving the JK1 segment, which is one of
four functional JK segments and is used most frequently in
VK-JK rearrangements (37). In this analysis, the number of
VK-JK rearrangements in sorted splenic K+ B cells was used
as the standard (100%) as described previously (22). Figure
4 shows a representative Southern blot analysis of PCR
amplified fragments after a 28 cycle amplification. Recom-
bined VK-JK fragments were detectable earlier in the postgraft-
ing period in donor-type CD45R+ cells from transgenic HSC
than in cells from non-transgenic HSC. This study indicates
that the presence of transgenic n chain indeed advanced the
onset of VK-J* rearrangements.
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CD45+ cells are capable of expressing slgM from a very
early developmental time. Thus, once early precursors acquire
in-frame VK-JK or Vx-Jx rearrangements, they would rapidly
express K or A. on the cell surface. As such, the rates of output
of BrdU-labeled K+ and X+ B cells should reflect the rates of
VK-JK and Vx-Jx rearrangements respectively.
Following 4 h of pulse BrdU labeling, BrdU was incorporated
by 31 and 29% of CD45R+slgM" B cell precursors from wild-
type and |i chain transgenic mice respectively. Figure 5(C)
shows the percentages of BrdU-labeled K+ and X+ B cells
among newly-generated B cells in the bone marrow (30). In
both groups of mice, the kinetics of BrdU-labeled K+ B cell
output as well as X+ B cell output were very similar. Following
the injection of BrdU, substantial fractions of BrdU-labeled
K+ and X+ B cells appeared at 12 and 36 h respectively, and
the percentages of BrdU-labeled K+ and X+ B cells reached
maximum levels by 36 and 72 h respectively. These observa-
tions indicate that n chain transgenic as well as wild-type
mice underwent K and X rearrangements with the same
kinetics after the arrest of cell cycling. The fraction of BrdU+
cells in n chain transgenic mice was consistently lower than
that in non-transgenic littermates. The number and/or rate of
cell division in early B cell precursors in (i chain transgenic
mice were likely smaller than in non-transgenic mice, causing
lower incorporation of BrdU on a single cell basis.
Rg. 4. PCR analyses of K rearrangements reveal that |i chain
expression from the transgene advances the onset of K
rearrangements during B cell development in the reconstituted mice.
On the indicated days after engraftment, donor-type CD45R+ cells
were isolated from recipient mice engrafted with wild-type HSC
and from recipient mice engrafted with HSC carrying the n chain
transgene Chromosomal DNA from 103 cells was amplified, blotted
and hybridized to analyze VK-JK pints and the Thy-1.2 gene (internal
control). The arrows show the sizes of the expected amplified
products. Data from the indicated numbers of slgM+ splenic B cells
(positive control) and ES cells (negative control) are also presented
The intensities of VK-JK1 joints are quantitated on appropriate
autoradiographic exposures. Under each lane, the extent of K
rearrangements is shown as a percentage of that in C57BL76 splenic
B cells. The data were corrected for variations in cell input based on
the Thy-1.2 gene amplification product.
The early expression of transgenic n chain did not activate
IgL rearrangements in early cycling B cell precursors
The engraftment of HSC revealed that early expression of the
\i chain from the transgene caused the early onset of K
rearrangements. In order to investigate whether or not early
expression of \i chain from the transgene activated K
rearrangements in the early cycling precursor stage, we
injected a single dose of BrdU i.p. into n chain transgenic
and non-transgenic mice to pulse-label cycling cells. In normal
B cell development (Fig. 5A), early cycling B cell precursors
(pro-B and large pre-B cells) are expected to incorporate
BrdU, while late resting B cell precursors (small pre-B cells),
which undergo IgL rearrangements, are not expected to
incorporate BrdU in the absence of cell division. The appear-
ance of K+ B cells at 8 days post-engraftment suggests that
Discussion
7776 expression of the n chain immediately drives early cycling
B precursors to differentiate into the late resting precursors.
We performed the following two experiments to study the
kinetics of B cell development comparing wild-type and \i
chain transgenic mice: transfer experiments where B cell
development from transferred HSC was followed over time
and BrdU-labeling experiments where B cell development
after the transition from the early cycling to the late resting
precursor stages was followed over time. The transfer experi-
ments showed that early expression of the n chain from
the transgene significantly reduced the duration of B cell
development from HSC to immature B cells. The BrdU-labeling
experiments showed that the presence of transgenic n chain
did not affect the length of the late resting precursor stage.
These observations suggest that early expression of the |i
chain from the transgene reduces the length of the early
cycling precursor stage.
This conclusion is consistent with previous studies that
measured the fraction of B cell precursors at different stages
in [i chain transgenic mice (2,35,38). These studies showed
that the presence of a n transgene reduced the proportion of
precursor B cells at an early stage. It should be noted that T
cell development apparently differs in this regard from B cell
development. TCR ap" thymocytes undergo V-J rearrange-
ments in the double-negative (DN, CD4~CD8~) stage. In
contrast to a striking decrease in the number of CD45R+slgM~
B cell precursors in HK transgenic mice (38), the number of
DN thymocytes was not reduced in TCR a£ transgenic mice
(39). Hence, DN thymocytes in TCR ap" transgenic mice may
need the same maturation time as required in wild-type mice
to differentiate into the next developmental stage by initiating
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Fig. 5. In vivo pulse BrdU labeling reveals that early expression of n chain from the transgene does not reduce the duration of the small pre-
B cell stage (A) Strategy for BrdU-labeling experiments. CD45R+ B lineage cells in the bone marrow were subdivided into four stages based
on the state of cell cycling and expression of the surrogate light chain (SL), \i chain and IgL chain Precursor cells at the pro-B and large pre-
B cell stages would be expected to incorporate BrdU. These cells should differentiate into resting small pre-B cells, which undergo IgL
rearrangements without incorporating BrdU. The appearance of BrdU-labeled B cells is thus dependent on the kinetics of productive IgL
rearrangements. (B) The histograms show the staining by anti-BrdU antibody The histogram on the left represents a negative control where
unlabeled CD45RlowslgM+ bone marrow cells were stained with anti-BrdU antibody. The histogram on the right shows anti-BrdU staining of
the CD45RtowslgM- bone marrow cells derived from mice pulse-labeled with BrdU for 4 h. The BrdU-labeled fraction is delineated by a
horizontal bar. (C) The appearance of BrdU-labeled ic+ B cells (solid line) and BrdU-labeled X+ B cells (dotted line) in the n chain transgenic
mice (closed circles) and their non-transgenic littermates (open circles) after a single injection of BrdU. At the indicated time after the injection
of BrdU, newly-generated ic+ and X+ B cells were isolated from the bone marrow and purified by cell sorting. Sorted cells were stained with
anti-BrdU antibody. The percentage of cells which were BrdU-labeled is displayed.
1326 y chain expression advances IgL rearrangements
cycling resting
I I
1.
proB large preB small preB
L rearrangements
H-chain expression
2.
Ig L rearrangements
(i-chain expression
3. T Ig L rearrangements|X-chain expression
4. T Ig L rearrangementsH-chain expression
Fig. 6. Early expression of the n chain from the transgene significantly reduced the duration of the pro-B cell stage but did not affect the small
pre-B cell stage B cell development in wild-type mice (first model) can be subdivided into two stages the early cycling precursor stage (pro-
B) and the late resting precursor stage (small pre-B) The stage where K and X rearrangements occur is shown by closed bars. In wild-type
mice, these rearrangements occur exclusively in precursors in the resting phase (first model). The present experiment revealed that, as shown
in the second model, early expression of the p. chain from the transgene immediately drove early cycling precursors into the late resting stage
(broken line), but did not affect the late resting precursor stage. The present experiments invalidated the third and fourth models The third
model predicts that HSC need a fixed maturation time to differentiate into the late resting stage, where IgL rearrangements occur. The fourth
model predicts that j i chain expression directly activates the IgL loci for V^J rearrangements, while the precursors are still proliferating.
the expression of other factors, in addition to the expression
of the transgenic TCR.
Figure 6 shows four models of the time course of B
cell development. Osmond estimated that the developmental
periods of the CD45R"TdT+pro-B, CD45R+pro-B, large pre-
B and small pre-B cell stages averaged 20, 18, 6.5 and 33 h
respectively in wild-type mice (Fig. 6, first model) (1). Early
precursors (prc-B) are mostly cycling and late precursors
(small pre-B) are in resting phase. Closed bars in Fig.
6 represent the developmental stage during which B cell
precursors undergo V-J rearrangements for IgL chain. These
rearrangements are normally initiated after the arrest of the
cell cycle (5,7). As shown by a dashed arrow in the second
model of Fig. 6, the present data suggest that, when the n
chain was artificially expressed by a transgene at a very
early developmental time, the precursors omitted subsequent
maturation steps in the early cycling precursor stage and
immediately differentiated into the late resting precursor stage.
Subsequently, the n chain transgenic mice underwent K and
X rearrangements after the arrest of cell cycling with the same
kinetics as wild-type mice.
The present experiments invalidate the other two models
of B cell development (Fig. 6, third and fourth models). In the
third model, although very early B cell precursors express
transgenic \i chain, they need the same length of maturation
time as wild-type precursors to differentiate into immature B
cells. The third model seems to apply to thymocyte develop-
ment in TCR ap transgenic mice as discussed before. In
the fourth model, early expression of transgenic \L chain
immediately activates the K and/or X locus for V-J rearrange-
ments while the precursor cells are cycling.
The arrest of cell cycling is an obligatory step in the induction
of IgL rearrangements
In normal B cell development the arrest of cell cycling
appeared to correlate closely with the initiation of IgL
rearrangements (6,7,40), but causality was not determined.
The present results showed that, despite the significant
reduction in the duration of the preceding pro-B stage, \i
chain transgenic mice initiated K and X rearrangements onty
after the arrest of cell cycling. This observation implies that
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the arrest of cell cycling is an obligatory step for K and X
rearrangements.
The induction of IgL rearrangements after the arrest of cell
cycling is reminiscent of the action of pro-B cell clones
established by Rolink etal. (41). The pro-B cell clones contain
DHJH/DHJH at the IgH locus and germline configurations at
the IgL loci; the clones divide in a self-renewing manner in
the presence of a feeder cell line, pA6 plus IL-7 (41). With
the removal of either pA6 or IL-7, the cells stop cycling, and
subsequently initiate K rearrangements. We found that even
the arrest of cell cycling by the addition of hydroxyurea
induced IgL rearrangements (unpublished data) These
observations imply that the arrest of cell cycling causes IgL
rearrangements both in vitro and in vivo.
Although Jn-deficient mice cannot generate late resting B
cell precursors, these mice can initiate low levels of VK-JK
rearrangements (8,22). This observation is not inconsistent
with the notion that K rearrangements are initiated upon the
arrest of the cell cycle We speculate that early B cell
precursors from JH-deficient mice undergo IgL rearrange-
ments only when these cells stop cell cycling before cell death
Expression of the n chain transduces signals to inhibit VH
to DHJH rearrangements, but presumably does not directly
activate the IgL genes for V-J recombination
We speculate that the expression of the \i chain does not
directly activate the IgL genes for V-J recombination, based
on the following observations. There are some pro-B clones
that contain abortive IgH rearrangements on both alleles, but
still undergo VK-JK rearrangements with the same kinetics as
normal pro-B cell clones (42). These data indicate that the
expression of the n chain does not facilitate IgL rearrange-
ments during the in vitro differentiation of pro-B clones. The
very efficient induction of K rearrangement in these pro-B cell
clones is more representative of B cell development in vivo
than the slower induction of K rearrangement observed in A-
MuLV transformed pre-B cell lines (19-21). Given that the
arrest of cell cycling apparently triggers IgL rearrangements
in vivo as well as in vitro, the expression of the \i chain
may not transduce signals to activate the IgL loci for V-J
rearrangements in vivo.
The rate of output ofBrdLf~K+ and BrdU+A* cells reflects the
kinetics of K and X rearrangements more precisely than
assessment of the number of V^^ joints by PCR
In order to analyze the kinetics of IgL rearrangements, previ-
ous studies measured the number of VK-JK joints in sorter-
purified precursors, using PCR (7,22,43). Although these
studies clearly showed the correlation between the expression
of surface markers and the state of V(D)J rearrangements,
we did not employ this method to assess the effect of n chain
expression on IgL rearrangements for the following three
reasons. Rrst, surface markers expressed on late resting B
cell precursors may differ between \i chain transgenic and
non-transgenic mice, because the length of the pro-B cell
stage in \y chain transgenic mice is significantly reduced.
While the expression of CD25 and c-kit on B cell precursors
is regulated by expression of the n chain (2,35,44), the
expression pattern of other surface markers appears to
correlate with the length of time after HSC begin differentiating
into B-lineage cells. In fact, each subfraction of B cell pre-
cursors, which was purified by cell sorter following Hardy's
method (6), contains precursors at various developmental
stages with respect to the status of V-J rearrangements (43).
Second, our previous study showed that sequential V^-J^
rearrangements on one chromosome occur up to three times
on average during B cell development, until in-frame VK-JK
rearrangements occur (45,46). The total number of VK-JK
joints measured by PCR does not reflect the presence of
sequential VK^-J* rearrangements, while the flow cytometric
analysis of BrdU+K+ B cells can accurately measure the
number of in-frame VK-JK joints. Third, the production rates
of small pre-B and B cells have been shown to be 1.7X107
and 1.6x 107 cells/day respectively, and the turnover of small
pre-B cells is 3%/h (1). These observations indicate that
virtually all late resting precursors in wild-type mice initiate
IgL rearrangements and that most of these precursors acquire
in-frame K rearrangements within 33 h. Such a rapid increase
in the number of VK-JK joints could not be accurately measured
by PCR.
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